DK3501534T5 - Vaccinesammensætninger omfattende en muteret faktor h-bindende protein - Google Patents
Vaccinesammensætninger omfattende en muteret faktor h-bindende protein Download PDFInfo
- Publication number
- DK3501534T5 DK3501534T5 DK18209661.0T DK18209661T DK3501534T5 DK 3501534 T5 DK3501534 T5 DK 3501534T5 DK 18209661 T DK18209661 T DK 18209661T DK 3501534 T5 DK3501534 T5 DK 3501534T5
- Authority
- DK
- Denmark
- Prior art keywords
- binding protein
- vaccine compositions
- mutated factor
- mutated
- factor
- Prior art date
Links
- 101710186862 Factor H binding protein Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0819633.9A GB0819633D0 (en) | 2008-10-25 | 2008-10-25 | Composition |
| EP09753188.3A EP2355845B1 (en) | 2008-10-25 | 2009-10-26 | Vaccine compositions comprising a mutated factor h binding protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3501534T3 DK3501534T3 (da) | 2024-02-05 |
| DK3501534T5 true DK3501534T5 (da) | 2024-09-02 |
Family
ID=40133849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18209661.0T DK3501534T5 (da) | 2008-10-25 | 2009-10-26 | Vaccinesammensætninger omfattende en muteret faktor h-bindende protein |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20120052092A1 (enExample) |
| EP (2) | EP2355845B1 (enExample) |
| JP (2) | JP5676458B2 (enExample) |
| KR (3) | KR20190011836A (enExample) |
| CN (2) | CN102245202A (enExample) |
| AU (1) | AU2009306114B2 (enExample) |
| BR (1) | BRPI0919926A2 (enExample) |
| CA (1) | CA2741619A1 (enExample) |
| CO (1) | CO6382140A2 (enExample) |
| DK (1) | DK3501534T5 (enExample) |
| ES (1) | ES2970878T3 (enExample) |
| FI (1) | FI3501534T3 (enExample) |
| GB (1) | GB0819633D0 (enExample) |
| HR (1) | HRP20240226T1 (enExample) |
| HU (1) | HUE065348T2 (enExample) |
| LT (1) | LT3501534T (enExample) |
| MX (1) | MX2011004322A (enExample) |
| NZ (2) | NZ601538A (enExample) |
| PL (1) | PL3501534T3 (enExample) |
| PT (1) | PT3501534T (enExample) |
| RU (1) | RU2559528C2 (enExample) |
| SI (1) | SI3501534T1 (enExample) |
| WO (1) | WO2010046715A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100379757C (zh) | 1998-05-01 | 2008-04-09 | 希龙公司 | 脑膜炎奈瑟球菌抗原和组合物 |
| BR0010721A (pt) | 1999-05-19 | 2002-06-11 | Chiron Spa | Composições de neisserias combinadas |
| PT2275551E (pt) | 1999-10-29 | 2015-06-29 | Novartis Vaccines & Diagnostic | Péptidos antigénicos de neisseria |
| ES2281409T3 (es) | 2000-02-28 | 2007-10-01 | Novartis Vaccines And Diagnostics S.R.L. | Expresion heterologa de proteinas de neisseria. |
| GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| DK2353608T3 (da) | 2002-10-11 | 2020-02-10 | Novartis Vaccines And Diagnostics S R L | Polypeptid-vacciner til bred beskyttelse mod hypervirulente meningokok-linjer |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| WO2009104097A2 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
| AU2009223613B2 (en) | 2008-03-10 | 2014-09-25 | Children's Hospital & Research Center At Oakland | Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use |
| CA2756522C (en) | 2009-03-24 | 2018-06-26 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
| WO2010127172A2 (en) | 2009-04-30 | 2010-11-04 | Children's Hospital & Research Center At Oakland | Chimeric factor h binding proteins (fhbp) and methods of use |
| US20130022633A1 (en) * | 2009-10-27 | 2013-01-24 | University Of Florence | MENINGOCOCCAL fHBP POLYPEPTIDES |
| JP2013521326A (ja) * | 2010-03-10 | 2013-06-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組成物 |
| BR122021020829B8 (pt) * | 2010-03-30 | 2022-12-27 | Children´S Hospital & Res Center At Oakland | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada |
| US10478483B2 (en) | 2010-06-25 | 2019-11-19 | Glaxosmithkline Biologicals Sa | Combinations of meningococcal factor H binding proteins |
| BR112014019166A2 (pt) | 2012-02-02 | 2017-07-04 | Novartis Ag | promotores para expressão aumentada de proteína em meningococos |
| WO2013186753A1 (en) | 2012-06-14 | 2013-12-19 | Novartis Ag | Vaccines for serogroup x meningococcus |
| HK1205138A1 (en) | 2012-07-27 | 2015-12-11 | Institut National De La Santé Et De La Recherche Médicale (Inserm) | Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| US20160030544A1 (en) * | 2013-03-14 | 2016-02-04 | Isis Innovation Limited | Immunogenic composition to neisseria |
| BR112016002150A2 (pt) | 2013-08-02 | 2017-09-12 | Children´S Hospital & Res Center At Oakland | proteínas de ligação de fator h de ocorrência natural (fhbp) e métodos de uso das mesmas |
| AU2015222121B2 (en) | 2014-02-28 | 2018-01-18 | Glaxosmithkline Biologicals Sa | Modified meningococcal fHbp polypeptides |
| KR102761870B1 (ko) | 2014-07-23 | 2025-02-05 | 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 | 인자 h 결합 단백질 변이체 및 이의 사용 방법 |
| AU2015304079B2 (en) * | 2014-08-20 | 2021-05-13 | Stichting Sanquin Bloedvoorziening | Factor H potentiating antibodies and uses thereof |
| GB201614687D0 (en) * | 2016-08-31 | 2016-10-12 | Univ Oxford Innovation Ltd | fHbp scaffold |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| MX2021007539A (es) | 2018-12-21 | 2021-09-21 | Univ Griffith | Composiciones, metodos y usos para provocar una respuesta inmune. |
| CA3147314A1 (en) * | 2019-07-08 | 2021-01-14 | J. McLeod GRIFFISS | Methods of making and using lipooligosaccharide compositions and vaccines |
| BR112022000739A2 (pt) | 2019-07-17 | 2022-04-12 | Gemini Therapeutics Sub Inc | Anticorpos de potencialização de fator h e usos dos mesmos |
| CA3211240A1 (en) | 2021-02-19 | 2022-08-25 | Sanofi Pasteur Inc. | Meningococcal b recombinant vaccine |
| TW202423477A (zh) | 2022-08-03 | 2024-06-16 | 美商賽諾菲巴斯德公司 | 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| US5476784A (en) * | 1993-04-06 | 1995-12-19 | Rice; Peter A. | Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| KR20060019515A (ko) * | 2003-04-16 | 2006-03-03 | 와이어쓰 홀딩스 코포레이션 | 수막구균 질환의 예방 및 치료용 신규 면역원성 조성물 |
| SI2682126T1 (sl) * | 2005-01-27 | 2017-03-31 | Children's Hospital & Research Center At Oakland | Cepiva na osnovi veziklov, osnovanih na GNA1870, za širokospektralno zaščito proti boleznim, povzročenim z Neisserio meningitidisom |
| GB0524066D0 (en) * | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| CA2656474A1 (en) * | 2006-06-29 | 2008-01-03 | Novartis Ag | Polypeptides from neisseria meningitidis |
| CN102596240B (zh) * | 2009-08-27 | 2015-02-04 | 诺华股份有限公司 | 包括脑膜炎球菌fHBP序列的杂交多肽 |
| BR122021020829B8 (pt) * | 2010-03-30 | 2022-12-27 | Children´S Hospital & Res Center At Oakland | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada |
-
2008
- 2008-10-25 GB GBGB0819633.9A patent/GB0819633D0/en not_active Ceased
-
2009
- 2009-10-26 NZ NZ601538A patent/NZ601538A/en not_active IP Right Cessation
- 2009-10-26 US US13/125,957 patent/US20120052092A1/en not_active Abandoned
- 2009-10-26 PL PL18209661.0T patent/PL3501534T3/pl unknown
- 2009-10-26 HU HUE18209661A patent/HUE065348T2/hu unknown
- 2009-10-26 EP EP09753188.3A patent/EP2355845B1/en not_active Not-in-force
- 2009-10-26 LT LTEP18209661.0T patent/LT3501534T/lt unknown
- 2009-10-26 KR KR1020197002691A patent/KR20190011836A/ko not_active Ceased
- 2009-10-26 ES ES18209661T patent/ES2970878T3/es active Active
- 2009-10-26 KR KR1020117011885A patent/KR20110092282A/ko not_active Ceased
- 2009-10-26 BR BRPI0919926A patent/BRPI0919926A2/pt not_active Application Discontinuation
- 2009-10-26 WO PCT/GB2009/051439 patent/WO2010046715A1/en not_active Ceased
- 2009-10-26 FI FIEP18209661.0T patent/FI3501534T3/fi active
- 2009-10-26 KR KR1020167035443A patent/KR20170000390A/ko not_active Ceased
- 2009-10-26 EP EP18209661.0A patent/EP3501534B1/en active Active
- 2009-10-26 PT PT182096610T patent/PT3501534T/pt unknown
- 2009-10-26 CA CA2741619A patent/CA2741619A1/en not_active Abandoned
- 2009-10-26 AU AU2009306114A patent/AU2009306114B2/en not_active Ceased
- 2009-10-26 CN CN2009801480003A patent/CN102245202A/zh active Pending
- 2009-10-26 NZ NZ592444A patent/NZ592444A/xx unknown
- 2009-10-26 CN CN201510119007.XA patent/CN105412920A/zh active Pending
- 2009-10-26 JP JP2011532725A patent/JP5676458B2/ja not_active Expired - Fee Related
- 2009-10-26 RU RU2011120706/10A patent/RU2559528C2/ru not_active IP Right Cessation
- 2009-10-26 SI SI200932190T patent/SI3501534T1/sl unknown
- 2009-10-26 MX MX2011004322A patent/MX2011004322A/es active IP Right Grant
- 2009-10-26 DK DK18209661.0T patent/DK3501534T5/da active
- 2009-10-26 HR HRP20240226TT patent/HRP20240226T1/hr unknown
-
2011
- 2011-05-05 CO CO11055224A patent/CO6382140A2/es not_active Application Discontinuation
-
2014
- 2014-12-25 JP JP2014261910A patent/JP6076326B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3501534T5 (da) | Vaccinesammensætninger omfattende en muteret faktor h-bindende protein | |
| DK2114993T3 (da) | Vaccine | |
| BRPI0917205A2 (pt) | vacina polivalente | |
| ATE450271T1 (de) | Impfstoff | |
| BRPI0917126A2 (pt) | implemento para cuidado oral | |
| PL2465864T3 (pl) | Szczepionki z peptydem pochodzącym z Eph4 | |
| BRPI0822833A2 (pt) | Implemento para cuidado oral | |
| BRPI0822817A2 (pt) | Implemento para cuidado oral | |
| BRPI0919626A2 (pt) | implante dental | |
| DK2252395T3 (da) | Afsvovlingsmaterialer | |
| BRPI0822868A2 (pt) | implemento para cuidado oral | |
| DK2194959T3 (da) | Skummedygtig mundplejetilberedning | |
| EP2019687A4 (en) | ANTI-STREPTOCOCCAL VACCINE | |
| FI20075180L (fi) | Käyttäjäystävällinen hammashoitokone | |
| NO20100811A (no) | Subenhetsvaksine for akvakutur | |
| BRPI0921578A2 (pt) | vacinas unitemporais | |
| DK2382224T3 (da) | Metalhydracid-materialer | |
| SE0800657L (sv) | Tandborste | |
| DK2335644T3 (da) | Oral rensedel | |
| DK2281524T3 (da) | Tandstolpe | |
| EP2320882A4 (en) | SYNTHETIC VACCINE COMPONENT | |
| EP2370100A4 (en) | PEPTIDE AGENTS | |
| DK2175881T3 (da) | Intradermal influenzavaccine | |
| DE112009001220A5 (de) | Motorbetriebenes Arbeitsgerät | |
| DE602007007336D1 (de) | Bürstenmaterial |